Atlas Trials

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Clinical trial NCT02187055 · COMPLETED

Trial details

NCT number
NCT02187055
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rhematoid Arthritis
Start date
2014-08-01
Primary completion
2016-12-01
Enrollment
1152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.